SCHEMBL30040122

SCHEMBL30040122

FC(F)(F)c1cc(OCc2nc3cc(Nc4ccccc4)ccc3[nH]2)ccn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 9/20 0.44
▸ NPC1 O15118 8/20 0.44
▸ SMN1; SMN2 Q16637 7/20 0.44
▸ TP53 P04637 5/20 0.44
▸ TSHR P16473 1/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ LMNA P02545 2/20 0.44
▸ MAPK1 P28482 2/20 0.44
▸ GAA P10253 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ PDE10A Q9Y233 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ HDAC1 Q13547 1/20 0.39
▸ HDAC8 Q9BY41 1/20 0.39
▸ HDAC6 Q9UBN7 1/20 0.39
▸ HDAC5 Q9UQL6 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25400113 1.00 RAB9A (0.44) RAB9ANPC1SMN1; SMN2TP53TSHR
SCHEMBL26260734 0.91 NPC1 (0.40) RAB9ANPC1SMN1; SMN2TP53TSHR
SCHEMBL30041546 0.88 RAB9A (0.41) RAB9ANPC1SMN1; SMN2TP53TSHR
SCHEMBL26260731 0.88 RAB9A (0.41) RAB9ANPC1SMN1; SMN2TP53TSHR
SCHEMBL26260736 0.88 SMN1; SMN2 (0.45) RAB9ANPC1SMN1; SMN2TP53TSHR
SCHEMBL30041208 0.88 SMN1; SMN2 (0.45) RAB9ANPC1SMN1; SMN2TP53TSHR
SCHEMBL26262050 0.84 RAB9A (0.47) RAB9ANPC1SMN1; SMN2TP53TSHR
SCHEMBL21612019 0.83 RAB9A (0.49) RAB9ANPC1SMN1; SMN2TP53TSHR
SCHEMBL25402812 0.82 CYP1A2 (0.42) TSHRPDE10AHDAC1HDAC6CYP1A2
SCHEMBL30040328 0.82 CYP1A2 (0.42) TSHRPDE10AHDAC1HDAC6CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4085054-A1 NEW PQSR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2022-11-09 — — EP disclosed
Send feedback